Fundraising Fox
/Companies
Sign in

Alveo

Alameda, US · Founded 2015 · Delaware corporation · 66 employees on LinkedIn · 5 known investors

Find your way into Alveo

Sign up to see every warm intro you have to Alveo

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Alveo team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Alveo Technologies makes a palm-sized molecular diagnostic analyzer with preloaded test cartridges that deliver on-site pathogen results in under an hour, with results sent to a smartphone. It targets point-of-need infectious disease detection, including avian influenza testing for poultry farms and workers.

AgTechBiotechMedical Devices

Founders & leadership

Alveo was founded in 2015 by Ron Chiarello.

RCRon Chiarello
Ron ChiarelloFounder, Board Chair and CEO2015–2021Ron Chiarello is a physicist with background from Argonne and Stanford who has spent two decades building companies in diagnostics, biotech, AI, and quantum hardware, with cumulative fundraising exceeding $250 million and an XPRIZE award.
MA
Michael AicherExecutive
SHShaun Holt
Shaun HoltChairman of the Board & Chief Executive Officer
ETErik Tyrrell-Knott
Erik Tyrrell-KnottPresident & Chief Business OfficerErik Tyrrell-Knott is President and Chief Business Officer of Alveo Technologies, which develops portable molecular diagnostic analyzers for point-of-care infectious disease detection. He has held business development and corporate development roles in life sciences companies ranging from startups to established global firms.
S
ScottChief Commercial Officer
SESlava Elagin
Slava ElaginExecutive (R&D/Operations)Slava Elagin is an executive with experience in in vitro diagnostics, medical devices, and biotechnology, holding advanced degrees (MBA and PhD) and having held leadership roles including VP and C-suite positions at publicly traded and private organizations. He brings expertise in R&D, operations, regulatory affairs, FDA interactions, and product development from research through commercialization in areas including molecular diagnostics and point-of-care testing.
M
MarcusSenior Vice President of Software Engineering

Board

IB
Isaac BlechBoard director
RS
Robin SteeleBoard director
LB
Lawrence BlattBoard director

Investors · 5

Celesta Capitallisted by Celesta CapitalSan Mateo · $5M – $10M

How we know: Celesta Capital's portfolio page · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us

Civilization Ventures Management, Llclisted by Civilization Ventures Management, LlcTiburon · $1M – $10M

How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Partners Resolutelisted by Partners ResoluteChicago

How we know: Partners Resolute's portfolio page · Not right? Tell us

SUPPLY CHANGE CAPITALreportedChicago · $200K – $1M

How we know: the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$63.6M disclosed across 2 rounds · 2016–2021

▶$16MraisedMar 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronald ChiarelloExecutive Officer, Director
  • Robin SteeleDirector
  • Lawrence BlattDirector
  • Julianne AverillExecutive Officer
  • Yuh-Min ChiangExecutive Officer
  • Nicholas BrathwaiteDirector
Offering amount
$30.1M
Amount sold
$16M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$47.6MraisedFeb 2018 · 248 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Isaac BlechDirector
  • Robin SteeleDirector
  • Michael AicherExecutive Officer, Director
  • Ron ChiarelloExecutive Officer, Director
  • Lawrence BlattDirector
Offering amount
$47.6M
Amount sold
$47.6M
Sales commissions
$3.1M
Placement agents
Maxim Group LLC
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Cerecor Inc.Avalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1β antibody.
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
AlveolusAlveolus Bio develops inhaled biotherapeutics for chronic and infectious lung diseases, using a platform that delivers targeted bacteria to the lungs to treat conditions such as idiopathic pulmonary fibrosis, NCFBE, and COPD. It serves patients with chronic and infectious respiratory conditions in the biotechnology and pharmaceutical space.

Companies working in the same space as Alveo.

Frequently asked questions

What does Alveo do?
Alveo Technologies makes a palm-sized molecular diagnostic analyzer with preloaded test cartridges that deliver on-site pathogen results in under an hour, with results sent to a smartphone. It targets point-of-need infectious disease detection, including avian influenza testing for poultry farms and workers.
Who founded Alveo?
Alveo was founded by Ron Chiarello in 2015.
Who are Alveo's investors?
Alveo's investors include Black Diamond Ventures, Celesta Capital, Civilization Ventures Management, Llc, Partners Resolute, SUPPLY CHANGE CAPITAL.
How much funding has Alveo raised?
Alveo has disclosed $63.6M raised across 2 rounds.
Where is Alveo headquartered?
Alveo is headquartered in Alameda, US.